Recorded live on Tuesday, December 1, 2020, from 2:00 PM ET to 3:00 PM ET • Hosted by the AST’s Vascularized Composite Allotransplantation Advisory Council (VCA AC)
"Vascularized composite allotransplantation in the United States: A retrospective analysis of the Organ Procurement and Transplantation Network data after 5 years of the Final Rule" (doi.org/10.1111/ajt.16086)
In this article:
On July 3, 2014, the Organ Procurement and Transplantation Network (OPTN) began overseeing vascularized composite allotransplantation/allografts (VCA) in the United States. For the past 6 years, centers performing VCAs have been requested to submit data into a biometric repository, in parallel with systems used by solid organ transplant centers. Currently, 62 VCAs are reported in the entire OPTN database, with 36 of these transplants reported as performed after VCA was added to the OPTN Final Rule... The present manuscript represents the query of a nationalized database for VCA type, immunosuppression treatment, and clinical outcomes for VCAs. This manuscript provides a report of the current VCA data reported to the OPTN after the Final Rule.
Holly Lewis MD, PhD • Duke University Medical Center, Durham, NC
Hatem Amer, MD, FASN, FAST • Mayo Clinic, Rochester, MN